Filippo Ansaldi

Filippo Ansaldi publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Filippo Ansaldi sits on this spectrum.

Filippo Ansaldi D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Filippo Ansaldi sits on this spectrum.

Best Publications

• Different seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in Italy

  Unknown

  213
  Citations

• Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies.

  Maria Pia Sormani;Matilde Inglese;Irene Schiavetti;Luca Carmisciano

  212
  Citations

• Hepatitis C virus in the new era: Perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy

  Unknown

  193
  Citations

• Influenza control in the 21st century: Optimizing protection of older adults.

  Arnold S. Monto;Filippo Ansaldi;Richard Aspinall;Janet E. McElhaney;Janet E. McElhaney

  173
  Citations

• Mother-to-infant transmission of hepatitis C virus: rate of infection and assessment of viral load and IgM anti-HCV as risk factors.

  Unknown

  150
  Citations

• Cross-protection by MF59-adjuvanted influenza vaccine: neutralizing and haemagglutination-inhibiting antibody activity against A(H3N2) drifted influenza viruses.

  Filippo Ansaldi;Sabrina Bacilieri;Paolo Durando;Laura Sticchi

  146
  Citations

• Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy

  Unknown

  143
  Citations

• Antibody response against heterogeneous circulating influenza virus strains elicited by MF59- and non-adjuvanted vaccines during seasons with good or partial matching between vaccine strain and clinical isolates.

  Filippo Ansaldi;Marta Zancolli;Paolo Durando;Emanuele Montomoli

  134
  Citations

• Novel Approach To Reduce the Hepatitis C Virus (HCV) Window Period: Clinical Evaluation of a New Enzyme-Linked Immunosorbent Assay for HCV Core Antigen

  Unknown

  130
  Citations

• Impaired Response to Influenza Vaccine Associated with Persistent Memory B Cell Depletion in Non-Hodgkin’s Lymphoma Patients Treated with Rituximab-Containing Regimens

  Davide Bedognetti;Gabriele Zoppoli;Gabriele Zoppoli;Carlotta Massucco;Elisa Zanardi;Elisa Zanardi

  114
  Citations

• Attitudes and Beliefs on Influenza Vaccination during the COVID-19 Pandemic: Results from a Representative Italian Survey.

  Alexander Domnich;Maura Cambiaggi;Alessandro Vasco;Luca Maraniello

  114
  Citations

• Universal childhood immunisation against Streptococcus pneumoniae: the five-year experience of Liguria Region, Italy.

  Paolo Durando;Pietro Crovari;Filippo Ansaldi;Laura Sticchi

  106
  Citations

• Safety and Immunogenicity of Two Influenza Virus Subunit Vaccines, with or without MF59 Adjuvant, Administered to Human Immunodeficiency Virus Type 1-Seropositive and -Seronegative Adults

  P. Durando;D. Fenoglio;A. Boschini;F. Ansaldi

  99
  Citations

• MF59-adjuvanted vaccine: a safe and useful tool to enhance and broaden protection against seasonal influenza viruses in subjects at risk

  Unknown

  96
  Citations

• Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells

  Michele Cea;Michele Cea;Debora Soncini;Floriana Fruscione;Lizzia Raffaghello

  95
  Citations

• Influenza and pneumococcal vaccinations of patients with systemic lupus erythematosus: current views upon safety and immunogenicity.

  Giuseppe Murdaca;Andrea Orsi;Francesca Spanò;Francesco Puppo

  92
  Citations

• Effectiveness of pneumococcal vaccines in preventing pneumonia in adults, a systematic review and meta-analyses of observational studies

  Unknown

  89
  Citations

• Changing molecular epidemiology of hepatitis C virus infection in Northeast Italy.

  Gianna Dal Molin;Filippo Ansaldi;Claudia Biagi;Pierlanfranco D'Agaro

  86
  Citations

• Adjuvants and alternative routes of administration towards the development of the ideal influenza vaccine.

  Unknown

  84
  Citations

• The impact of 10-valent and 13-valent pneumococcal conjugate vaccines on hospitalization for pneumonia in children: A systematic review and meta-analysis

  Unknown

  84
  Citations